London, United Kingdom

Mariam Jamal-hanjani

This inventor holds 1 USPTO granted patent. Top assignee: Natera, Inc.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mariam Jamal-hanjani. Retrieved from https://idiyas.com/inventor/mariam-jamal-hanjani

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mariam Jamal-Hanjani: Innovator in Lung Cancer Detection

Introduction

Mariam Jamal-Hanjani is a prominent inventor based in London, GB. She has made significant contributions to the field of cancer detection, particularly focusing on lung cancer. Her innovative work has the potential to improve early diagnosis and treatment options for patients.

Latest Patents

Mariam holds a patent for "Methods for lung cancer detection." This invention provides methods for detecting single nucleotide variants in lung cancer, especially in cases of stage 3a lung adenocarcinoma and lung squamous cell carcinoma. The patent also includes additional methods and compositions, such as reaction mixtures and solid supports comprising clonal populations of nucleic acids.

Career Highlights

Mariam is currently associated with Natera, Inc., where she continues to advance her research in cancer diagnostics. Her work is crucial in the ongoing battle against lung cancer, a disease that affects millions worldwide.

Collaborations

Mariam has collaborated with notable professionals in her field, including Bernhard Zimmermann and Tudor Pompiliu Constantin. These partnerships enhance her research and contribute to the development of innovative solutions in cancer detection.

Conclusion

Mariam Jamal-Hanjani is a trailblazer in the field of lung cancer detection, with her patent and ongoing work promising to make a significant impact on patient care. Her dedication to innovation in medical technology is commendable and essential for advancing cancer diagnostics.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…